{"contentid": 488549, "importid": NaN, "name": "Novo Nordisk beats expectations in quarterly results", "introduction": "Danish diabetes giant Novo Nordisk exceeded analysts\u00e2\u0080\u0099 forecasts with its first quarter financial results, presented on Wednesday.", "content": "<p>Danish diabetes giant Novo Nordisk (NOV: N) exceeded analysts&rsquo; forecasts with its first quarter 2021 financial results, presented on Wednesday.</p>\n<p>Reported net sales came in unchanged compared to a year ago, at 33.8 billion Danish kroner ($5.46 billion), above a forecast of 32.5 billion kroner in a Refinitiv poll.</p>\n<p>The company&rsquo;s reported quarterly operating profit of 14.98 billion Danish kroner was above the average of 14.6 billion kroner expected by analysts.</p>\n<h2>Improved guidance</h2>\n<p>Novo Nordisk has raised its financial forecast for the year as a whole. The group now expects sales growth in local currencies for 2021 at between 6% and 10%, up from a previous 5% to 9%, and operating profit growth in local currencies in the range of 5% to 9%, an increase from the prior estimate of 4% to 8%.</p>\n<p>Shares in the company&rsquo;s share price closed marginally higher after Wednesday&rsquo;s trading.</p>\n<p>Lars Fruergaard J&oslash;rgensen, president and chief executive of Novo Nordisk, said: &ldquo;We are very encouraged with the sales growth in the first three months of 2021. Sales growth was driven by all therapy areas and across geographical areas within International Operations as well as North America Operations where growth has accelerated in the USA.</p>\n<p>&ldquo;We were also pleased to announce plans to develop oral semaglutide as a convenient and effective treatment option for people with obesity, complementing our injectable obesity medications. The solid financial performance in the first three months of 2021 has enabled us to raise our outlook range for the full year.&rdquo;</p>\n<h2>Key product sales</h2>\n<p>Victoza (liraglutide): 3.91 billion kroner, down 22% in local currencies</p>\n<p>Ozempic (semaglutide): 6.66 billion kroner, up 40%</p>\n<p>Tresiba (insulin degludec): 2.37 billion kroner, down 4%</p>\n<p>NovoMix (insulin aspart): 2.53 billion kroner, down 3%</p>\n<p>NovoRapid (insulin aspart): 4.15 billion kroner, down 12%</p>", "date": "2021-05-05 18:41:00", "meta_title": NaN, "meta_keywords": "billion, Novo, Nordisk, kroner, results, Danish, financial, sales, growth, quarterly, expectations, beats, exceeded, forecasts, giant, diabetes, presented", "meta_description": "Danish diabetes giant Novo Nordisk exceeded analysts\u00e2\u0080\u0099 forecasts with its first quarter financial results, presented on Wednesday.", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 1, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-05-05 18:34:40", "updated": "2021-05-05 20:07:32", "access": NaN, "url": "https://www.thepharmaletter.com/article/novo-nordisk-beats-expectations-in-quarterly-results", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "novo_nordisk_2021_night.jpg", "image2id": "novo_nordisk_2021_night_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Pharmaceutical", "therapy area_tag": "Diabetes, Endocrinology, Metabolics", "topic_tag": "Financial, Management", "geography_tag": "Denmark", "company_tag": "Novo Nordisk", "drug_tag": "NovoMix, NovoRapid, Ozempic, Tresiba, Victoza", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-05-05 18:41:00"}